Cavrotolimod
Cavrotolimod is an immunostimulatory spherical nucleic acid (SNA) modified with type B CpG oligonucleotides designed to agonize TLR9 and elicit immune responses useful in oncology applications.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2378664-12-9
- Fòrmula: C300H423N71O161P26S23
- Peso molecular:9142.88
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Chemical Information
-
No. CAS 2378664-12-9
-
Peso molecular 9142.88
-
Fòrmula C300H423N71O161P26S23
-
SMILES
[Cavrotolimod]
-
Synonyms
AST-008
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Daniel WL, Lorch U, Mix S, Bexon AS. A first-in-human phase 1 study of cavrotolimod, a TLR9 agonist spherical nucleic acid, in healthy participants: Evidence of immune activation. Front Immunol. 2022;13:1073777. [Content Brief]
[2]. Rubatto M, Sciamarrelli N, Borriello S, et al. Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer. Front Med (Lausanne). 2023;9:959289. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)